Kura Oncology Inc —— 季度现金流量表 (NASDAQ:KURA) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 760.16 M743.76 M682.42 M649.38 M738.36 M 负债总额 346.52 M379.36 M376.94 M406.84 M564.23 M 权益总额 413.64 M364.41 M305.49 M242.54 M174.13 M 负债及股东权益总额 760.16 M743.76 M682.42 M649.38 M738.36 M 总债务 9.52 M9.57 M9.62 M9.67 M9.71 M 净债务 -717.87 M-648.62 M-621.11 M-539.99 M-657.53 M

新闻

Kura Oncology: Commercialization In AML Presents Asymmetric Upside (NASDAQ:KURA)

UBS因上市数据将Kura Oncology目标价下调至15美元

UBS lowers Kura Oncology stock price target to $15 on launch data

Kura Oncology在Leerink全球医疗保健会议上的战略扩张洞察

Kura Oncology at Leerink Global Healthcare Conference: Strategic Expansion Insights

Kura Oncology, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:KURA) 2026-03-06

Citizens重申Kura Oncology股票评级,看好强劲上市表现

Citizens reiterates Kura Oncology stock rating on strong launch

Kura Oncology (KURA) Reports Q4 Loss, Misses Revenue Estimates

Kura OncologyQ1每股收益及营收逊于预期

Kura Oncology Inc earnings missed by $0.66, revenue fell short of estimates

Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline